L, P., J, L., S, K., Y, J., X, G., X, J., & H, D. (2026). Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic Stroke. CNS drugs, 40(5), 657. https://doi.org/10.1007/s40263-026-01278-9
Chicago Style (17th ed.) CitationL, Pu, Liu J, Kong S, Joyama Y, Gong X, Ji X, and Dong H. "Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic Stroke." CNS Drugs 40, no. 5 (2026): 657. https://doi.org/10.1007/s40263-026-01278-9.
MLA (9th ed.) CitationL, Pu, et al. "Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic Stroke." CNS Drugs, vol. 40, no. 5, 2026, p. 657, https://doi.org/10.1007/s40263-026-01278-9.
Warning: These citations may not always be 100% accurate.